EMEA-001262-PIP01-12-M03
Key facts
| Active substance |
Dobutamine
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/0182/2017
|
| PIP number |
EMEA-001262-PIP01-12-M03
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Treatment of neonatal circulatory failure
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Proveca Limited
Tel. +44 7913048665 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|